These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IkappaB-alpha represses the transcriptional activity of the HIV-1 Tat transactivator by promoting its nuclear export. Puca A; Fiume G; Palmieri C; Trimboli F; Olimpico F; Scala G; Quinto I J Biol Chem; 2007 Dec; 282(51):37146-57. PubMed ID: 17942396 [TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-3 mediates HIV-1 transactivation via NFκB and JNK pathways and histone acetylation, but prolonged activation suppresses Tat and HIV-1 replication. Bhargavan B; Woollard SM; Kanmogne GD Cell Signal; 2016 Feb; 28(2):7-22. PubMed ID: 26569339 [TBL] [Abstract][Full Text] [Related]
6. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin B-oligomer. Rizzi C; Alfano M; Bugatti A; Camozzi M; Poli G; Rusnati M Eur J Immunol; 2004 Feb; 34(2):530-6. PubMed ID: 14768058 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat. Cheng H; Tarnok J; Parks WP J Virol; 1998 Aug; 72(8):6911-6. PubMed ID: 9658145 [TBL] [Abstract][Full Text] [Related]
10. Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium? Lothrop AP; Snider GW; Ruggles EL; Hondal RJ Biochemistry; 2014 Jan; 53(3):554-65. PubMed ID: 24393022 [TBL] [Abstract][Full Text] [Related]
11. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
12. Transactivation of gene expression by NF-κB is dependent on thioredoxin reductase activity. Heilman JM; Burke TJ; McClain CJ; Watson WH Free Radic Biol Med; 2011 Oct; 51(8):1533-42. PubMed ID: 21782934 [TBL] [Abstract][Full Text] [Related]
13. Transcriptional control of HIV replication by multiple modulators and their implication for a novel antiviral therapy. Victoriano AF; Okamoto T AIDS Res Hum Retroviruses; 2012 Feb; 28(2):125-38. PubMed ID: 22077140 [TBL] [Abstract][Full Text] [Related]
14. Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. Taylor JP; Pomerantz RJ; Raj GV; Kashanchi F; Brady JN; Amini S; Khalili K J Virol; 1994 Jun; 68(6):3971-81. PubMed ID: 8189531 [TBL] [Abstract][Full Text] [Related]
15. Methylation of Tat by PRMT6 regulates human immunodeficiency virus type 1 gene expression. Boulanger MC; Liang C; Russell RS; Lin R; Bedford MT; Wainberg MA; Richard S J Virol; 2005 Jan; 79(1):124-31. PubMed ID: 15596808 [TBL] [Abstract][Full Text] [Related]
16. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Majello B; De Luca P; Hagen G; Suske G; Lania L Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480 [TBL] [Abstract][Full Text] [Related]
17. Nrf2 is involved in inhibiting Tat-induced HIV-1 long terminal repeat transactivation. Zhang HS; Li HY; Zhou Y; Wu MR; Zhou HS Free Radic Biol Med; 2009 Aug; 47(3):261-8. PubMed ID: 19409485 [TBL] [Abstract][Full Text] [Related]
18. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappa B--a review. Taylor JP; Khalili K Adv Neuroimmunol; 1994; 4(3):291-303. PubMed ID: 7874398 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1. Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279 [TBL] [Abstract][Full Text] [Related]
20. Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression. Wang M; Yang W; Chen Y; Wang J; Tan J; Qiao W Retrovirology; 2018 Sep; 15(1):65. PubMed ID: 30241541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]